38132159|t|Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase Inhibitors.
38132159|a|Amyloid beta (Abeta) deposition within the brain vasculature is an early hallmark of Alzheimer's disease (AD), which triggers loss of brain vascular smooth muscle cells (BVSMCs) in cerebral arteries, via poorly understood mechanisms, altering cerebral blood flow, brain waste clearance, and promoting cognitive impairment. We have previously shown that, in brain endothelial cells (ECs), vasculotropic Abeta species induce apoptosis through death receptors (DRs) DR4 and DR5 and mitochondria-mediated mechanisms, while FDA-approved carbonic anhydrase inhibitors (CAIs) prevent mitochondria-mediated EC apoptosis in vitro and in vivo. In this study, we analyzed Abeta-induced extrinsic and intrinsic (DR- and mitochondria-mediated) apoptotic pathways in BVSMC, aiming to unveil new therapeutic targets to prevent BVSMC stress and death. We show that both apoptotic pathways are activated in BVSMCs by oligomeric Abeta42 and Abeta40-Q22 (AbetaQ22) and mitochondrial respiration is severely impaired. Importantly, the CAIs methazolamide (MTZ) and acetazolamide (ATZ) prevent the pro-apoptotic effects in BVSMCs, while reducing caspase 3 activation and Abeta deposition in the arterial walls of TgSwDI animals, a murine model of cerebral amyloid angiopathy (CAA). This study reveals new molecular targets and a promising therapeutic strategy against BVSMC dysfunction in AD, CAA, and ARIA (amyloid-related imaging abnormalities) complications of recently FDA-approved anti-Abeta antibodies.
38132159	202	207	Abeta	Gene	11820
38132159	273	292	Alzheimer's disease	Disease	MESH:D000544
38132159	294	296	AD	Disease	MESH:D000544
38132159	489	509	cognitive impairment	Disease	MESH:D003072
38132159	590	595	Abeta	Gene	11820
38132159	659	662	DR5	Gene	21933
38132159	849	854	Abeta	Gene	11820
38132159	941	946	BVSMC	Disease	
38132159	1000	1005	BVSMC	Disease	
38132159	1208	1221	methazolamide	Chemical	MESH:D008704
38132159	1223	1226	MTZ	Chemical	MESH:D008704
38132159	1232	1245	acetazolamide	Chemical	MESH:D000086
38132159	1247	1250	ATZ	Chemical	MESH:D000086
38132159	1312	1321	caspase 3	Gene	12367
38132159	1337	1342	Abeta	Gene	11820
38132159	1397	1403	murine	Species	10090
38132159	1413	1440	cerebral amyloid angiopathy	Disease	MESH:D016657
38132159	1442	1445	CAA	Disease	MESH:D016657
38132159	1534	1539	BVSMC	Disease	
38132159	1555	1557	AD	Disease	MESH:D000544
38132159	1559	1562	CAA	Disease	MESH:D016657
38132159	1568	1572	ARIA	Disease	MESH:C564543
38132159	1574	1611	amyloid-related imaging abnormalities	Disease	MESH:C564543
38132159	1657	1662	Abeta	Gene	11820
38132159	Association	MESH:C564543	11820
38132159	Negative_Correlation	MESH:D000086	MESH:D016657
38132159	Negative_Correlation	MESH:D008704	12367
38132159	Negative_Correlation	MESH:D008704	11820
38132159	Association	11820	21933
38132159	Association	MESH:D000544	11820
38132159	Association	MESH:D003072	11820
38132159	Association	MESH:D016657	11820
38132159	Negative_Correlation	MESH:D000086	11820
38132159	Negative_Correlation	MESH:D000086	12367

